Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 9, 2010, Pages 1655-1662

  Chernin, Gil ^a   Vega Warner, Virginia ^a   Schoeb, Dominik S ^a   Heeringa, Saskia F ^a   Ovunc, Bugsu ^a   Saisawat, Pawaree ^a   Cleper, Roxana ^b   Ozaltin, Fatih ^c   Hildebrandt, Friedhelm ^a,d   Arbeiter, A ^e   Bakkalogulu, A ^e   Benz, M ^e   Bockenhauer, D ^e   Bogdanovic, R ^e   Chandha, V ^e   Ettenger, R ^e   Ghossein, C ^e   Goldberg, A ^e   Heiliczer, J ^e   Hooper, D ^e   Hoppe, B ^e   Jenkins, R ^e   Kaplan, B ^e   Kemper, M J ^e   Konrad, M ^e   London, R ^e   Mache, C ^e   Mansoor, O ^e   Mayr, M ^e   Neuhaus, T ^e   Plank, C ^e   Reusz, G ^e   Rinat, C ^e   Seeman, T ^e   Strecker, M ^e   Taranta Janusz, K ^e   Weigel, F ^e   Zolotnitskaya, A ^e   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c HACETTEPE UNIVERSITY   (Turkey)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

WT1 PROTEIN;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; DONOR; FAMILY; FEMALE; FRASIER SYNDROME; GENE DELETION; GENETIC RISK; GENOTYPE; HUMAN; INTRON; KARYOTYPE; KARYOTYPE 46,XY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEPHROBLASTOMA; NEPHROTIC SYNDROME; NONSENSE MUTATION; OUTCOME ASSESSMENT; PHENOTYPE; PROPHYLAXIS; TUMOR;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CODON, NONSENSE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FRASIER SYNDROME; GENES, WILMS TUMOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GONADOBLASTOMA; HUMANS; INFANT; INTRONS; ISRAEL; KAPLAN-MEIER ESTIMATE; KARYOTYPING; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MUTATION; MUTATION, MISSENSE; NEPHROTIC SYNDROME; PEDIGREE; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SEQUENCE DELETION; TIME FACTORS; TURKEY; UNITED STATES; WILMS TUMOR;

EID: 77957315050     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09351209     Document Type: Article

References (34)

1. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437-447, 1991
2. Barbaux S, Niaudet P, Gubler MC, Grünfeld JP, Jaubert F, Kuttenn F, Fékété CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K: Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17: 467-470, 1997
3. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, Everding AS, Neuhaus T, Patzer L, Plank C, Haas JP, Ozaltin F, Imm A, Fuchshuber A, Bakkaloglu A, Hildebrandt F; APN Study Group: Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 66: 564-570, 2004
4. Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bogdanovic R, Seeman T, Hoppe B, Hildebrandt F; Members of the APN Study Group: Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59: 325-331, 2006
5. Drash A, Sherman F, Hartmann WH, Blizzard RM: A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76: 585-593, 1970
6. Niaudet P, Gubler MC: WT1 and glomerular diseases. Pediatr Nephrol 21: 1653-1660, 2006
7. Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M, Broyer M: The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): A distinctive glomerular lesion - report of 10 cases. Clin Nephrol 24: 269-278, 1985
8. Little M, Wells C: A clinical overview of WT1 gene mutations. Hum Mutat 9: 209-225, 1997
9. Mrowka C, Schedl A: Wilms' tumor suppressor gene WT1: From structure to renal pathophysiologic features. J Am Soc Nephrol 11: S106-S115, 2000
10. Baird PN, Santos A, Groves N, Jadresic L, Cowell JK: Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1: 301-305, 1992
11. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M: Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1+/-KTS splice isoforms. Hum Mol Genet 7: 709-714, 1998 (Pubitemid 28152270)
12. Hu M, Zhang GY, Arbuckle S, Graf N, Shun A, Silink M, Lewis D, Alexander SI: Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene. Nephrol Dial Transplant 19: 223-226, 2004 (Pubitemid 38072637)
13. Love JD, DeMartini SD, Coppola CP: Prophylactic bilateral salpingo-oopherectomy in a 17-year-old with Frasier syndrome reveals gonadoblastoma and seminoma: A case report. J Pediatr Surg 41: e1-e4, 2006
14. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F: Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
15. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F: Arbeitsgemeinschaft für Paediatrische Nephrologie Study Group: Nephrotic syndrome in the first year of life: Two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119: e907-e919, 2007
16. Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antignac C, Wiggins RC, Zenker M, Hildebrandt F: Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23: 1291-1297, 2008
17. Bockenhauer D, van't Hoff W, Chernin G, Heeringa SF, Sebire NJ: Membranoproliferative glomerulonephritis associated with a mutation in Wilms' tumour suppressor gene 1. Pediatr Nephrol 24: 1399-1401, 2009
18. International study of kidney disease in children: Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity: A report of the International Study of kidney disease in children. Kidney Int 20: 765-771, 1981 (Pubitemid 12169014)
19. Arbeitsgemeinschaft für Pädiatrische Nephrologie: Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1: 380-383, 1988
20. Schumacher V, Schärer K, Wühl E, Altrogge H, Bonzel KE, Guschmann M, Neuhaus TJ, Pollastro RM, Kuwertz- Bröking E, Bulla M, Tondera AM, Mundel P, Helmchen U, Waldherr R, Weirich A, Royer-Pokora B: Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 53: 1594-1600, 1998
21. Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, Yamada M: Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14: 466-470, 1999
22. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, Papathanasiou A, Tar A, Merksz M, Györvári B, Sultan C, Dumas R, Jaubert F, Niaudet P, Moreira-Filho CA, Cotinot C, Fellous M: The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 13: 146-153, 1999 (Pubitemid 29059154)
23. Tajima T, Sasaki S, Tanaka Y, Kusunoki H, Nagashima T, Nonomura K, Fujieda K: 46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation. Horm Res 60: 302-305, 2003 (Pubitemid 37499950)
24. Melo KF, Martin RM, Costa EM, Carvalho FM, Jorge AA, Arnhold IJ, Mendonca BB: An unusual phenotype of Frasier syndrome due to IVS9 + 4 C>T mutation in the WT1 gene: Predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab 87: 2500-2505, 2002
25. Denamur E, Bocquet N, Mougenot B, Da Silva F, Martinat L, Loirat C, Elion J, Bensman A, Ronco PM: Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol 10: 2219-2223, 1999 (Pubitemid 29453501)
26. Heathcott RW, Morison IM, Gubler MC, Corbett R, Reeve AE: A review of the phenotypic variation due to the Denys- Drash syndrome-associated germline WT1 mutation R362X. Hum Mutat 19: 462, 2002
27. Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B: Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 15: 3972-3977, 1997 (Pubitemid 27180483)
28. Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, Weirich A, Huff V: Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A 15: 249-257, 2004 (Pubitemid 38685865)
29. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cécille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C: Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62: 824-833, 1998
30. Rao A, Rothman J, Nichols KE: Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20: 1-7, 2008
31. American Society of Clinical Oncology: American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 21: 2397-2406, 2003
32. Eddy AA, Mauer SM: Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): Frequency in end-stage renal failure. J Pediatr 106: 584-587, 1985
33. Guzzo I, Mancini E, Wafo SK, Ravà L, Picca S: Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol 24: 1391-1397, 2009
34. Krediet RT: How to preserve residual renal function in patients with chronic kidney disease and on dialysis. Nephrol Dial Transplant 21[Suppl 2]: ii42-ii46, 2006